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X-ray crystal structures show DNA stacking advantage of 
terminal nitrile substitution in Ru-dppz complexes 
Kane McQuaid[a,c], James P. Hall[a,b,c], John A. Brazier[b], David J. Cardin[a] and Christine J. Cardin[a]* 
Abstract: The new complexes [Ru(TAP)2(11-CN-dppz)]2+,  
[Ru(TAP)2(11-Br-dppz)]2+and [Ru(TAP)2(11,12-diCN-dppz)]2+ are 
reported. The addition of nitrile substituents to the dppz ligand of 
the DNA photooxidising complex [Ru(TAP)2(dppz)]2+ promote π-
stacking interactions and ordered binding to DNA, as shown by 
X-ray crystallography. 
The structure of -[Ru(TAP)2(11-CN-dppz)]2+ with the DNA 
duplex d(TCGGCGCCGA)2 shows, for the first time with this 
class of complex, a closed intercalation cavity with an AT base 
pair at the terminus. The structure obtained is compared to that 
formed with the 11-Br and 11,12-dinitrile derivatives, highlighting 
the stabilization of syn guanine by this enantiomer when the 
terminal basepair is GC. In contrast the AT basepair has the 
normal Watson-Crick orientation, highlighting the difference in 
charge distribution between the two purine bases and the 
complementarity of the dppz-purine interaction. The asymmetry 
of the cavity highlights the importance of the purine-dppz-purine 
stacking interaction. 
 
Introduction 
The complex [Ru(phen)2(dppz)]2+ and its derivatives have been 
extensively studied since the original demonstration of the DNA 
‘light-switch’ effect using [Ru(bpy)2(dppz)]2+ (phen = 
phenanthroline, dppz = dipyridophenazine and bpy = 
bipyridine).[1] These complexes, and close derivatives, have 
been shown to be able to act as structure specific luminescent 
probes for mismatched DNA,[2,3] and for G-quadruplexes.[4,5] 
Related complexes can oxidise guanine upon irradiation,[6–9] 
explicitly directing DNA damage.[10] Such damage pathways are 
utilized in the study of anti-cancer photodynamic therapies 
(PDT)  [11–16] for which ruthenium polypyridyl complexes are 
considered promising candidates for the next generation of  
photosensitizers. [13,16,17] The extension of the dppz ligand with 
additional rings for example, leads to powerful anti-tumour 
properties.[18–20] Gaining insight into the manner in which these 
complexes bind to their target is therefore of importance, where 
a deeper structural knowledge allows for the superior design of 
more specific DNA binders. In one recent report, for example, a  
rapid screening approach was used to identify structural 
selectivity using racemic mixtures of a range of halide 
derivatives of [Ru(bpy)2dppz]2+, and including the 11-Br 
analogue of the complex, studied in this work.[21]  
[Ru(TAP)2(bpy)]2+ (TAP = 1,4,5,8-tetraazaphenanthrene) has 
been shown to covalently link to guanine upon irradiation[6] and 
the TAP ligand was subsequently used to form the 
photooxidising and DNA intercalating [Ru(TAP)2(dppz)]2+ 
complex.[22] That complex is the parent compound of the three 
derivatives reported here (Figure 1a). A detailed review of the 
photooxidation kinetics of [Ru(TAP)2(dppz)]2+ with sequence 
specific guanine oligonucleotides has recently been 
published.[23] The biophysical and solution behaviour of these 
complexes was intensively investigated in the absence of a 
structural model, until our publication in 2011[24] highlighting the 
binding of Λ-[Ru(TAP)2(dppz)]2+ to the DNA decamer sequence 
d(TCGGCGCCGA)2, and, the following year, the binding of Λ-
[Ru(phen)2(dppz)]2+ to the sequence d(CCGGTACCGG)2.[25] The 
complexes were shown to intercalate from the minor groove of 
the B-DNA, as confirmed by several further studies.[26] The 
primary stabilising interaction was shown to be the stacking 
between the DNA bases and the dppz ligand. The angle of the 
(canted) intercalation was subsequently shown to be determined 
by a secondary stacking interaction between the phen or TAP 
ancillary  ligand and the 2’-deoxyribose sugar of one of the four 
bases forming the intercalation cavity, thus altering the 
Figure 1 –  Illustrations of (a) structures of the  reported complexes  -
[Ru(TAP)2(11-CN-dppz)]2+ (I), -[Ru(TAP)2(11-Br-dppz)]2+ (II) and  -
[Ru(TAP)2(11,12-diCN-dppz)]2+ (III); (b) Stick plot of (I) showing the 
numbering scheme used throughout the text. Carbon atoms are coloured 
cyan, nitrogen – dark blue, ruthenium – teal and hydrogen – white; (c) 
oligonucleotides used in the study highlighting the standard nucleobase 
colouring used throughout.  
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photophysical properties of the bound complexes.[27] This 
binding mode is now seen to be the dominant binding mode for 
both enantiomers of [Ru(L)2(dppz)]2+ (where L = bidentate N-
heterocycle). The only exception recorded so far is the 
symmetrical binding of the lambda enantiomer to a central 
TA/TA step, which we now believe can only be seen at this 
site.[25] In this binding mode there is a high twist angle of nearly 
40, with a secondary interaction with the two symmetrically 
equivalent phen ligands.  
We were able to show that the angled intercalation mode is also 
seen for [Ru(bpy)2(dppz)]2+ and [Ru(phen)2(11,12-Me2-dppz)]2+ 
using a different DNA sequence, and also hypothesised that the 
angled (canted) intercalation mode seen at the symmetrical 
CG/CG step is a structural consequence of the projection of the 
2-NH2 group of guanine into the minor groove.[28] More recently 
these structural observations have been used to interpret 
longstanding discussions in the literature about observations of 
multiple luminescence lifetimes even in apparently 
homogeneous Ru-DNA model systems.[29] The realisation that 
the typical binding mode for these complexes is angled 
intercalation prompted the investigation of the effect of 
asymmetric substitution of the distal ring of the dppz ligand[30] 
(positions 10-13 in Figure 1b).  
 
Here we report the crystal structure of rac-[Ru(TAP)2(11-CN-
dppz)]2+ (I), and the structural consequences of binding to the 
DNA duplex d(TCGGCGCCGA)2, with a comparison to the 
CG/CG terminal step (Figure 1c). The phen analogue of this 
compound was recently described for potential photodynamic 
therapy applications.[14] The duplex is that used in our original 
publication from 2011,[24] and our intention was to investigate the 
effect of electron withdrawing substituents with useful infrared 
reporting groups,[31] and which could be accommodated in the 
solvent space of the well understood crystal packing.[32]  We 
make two comparisons, using two more new complexes – with 
the -11-Br analogue (II) bound to the same sequence, and  
with the symmetric disubstituted -[Ru(TAP)2(11,12-diCN-
dppz)]2+ (III) to an asymmetric decamer sequence. 
We have previously observed with different derivatives of -
[Ru(TAP)2(dppz)]2+ that intercalation into the terminal TC/GA 
base step can force the terminal adenine (A10) to flip out and 
form a reverse Watson-Crick base pair with a symmetry related 
strand.[27] Therefore, as illustrated in Figure 2, the ‘purine side’ of 
the intercalation cavity was incomplete, even for an 
unsubstituted dppz. Perhaps most strikingly, we found that 
reversible dehydration of our original crystal exhibited a 
remarkable reversal, with the dehydrated form showing that the 
‘purine side’ of the intercalation cavity was now intact, but the 
‘pyrimidine side’ instead was the one which had flipped out.[33] In 
this work we report that -11-nitrile substitution gives us the first 
example of a complete TC/GA cavity at this terminal 
intercalation step, with the asymmetry of the cavity suggesting 
that the addition of a nitrile moiety can generate additional 
favourable π orbital overlap, perhaps leading to enhanced 
specificity for DNA binding. t
Results 
Synthesis and crystal structure of (I) with 
d(TCGGCGCCGA)2. [Ru(TAP)2(11-CN-dppz)]2+ (I) was 
synthesized using a variation of a previously published method 
as both the PF6- and Cl- salts. The racemic PF6- salt was 
recrystallized from acetonitrile via the vapour diffusion of diethyl 
ether to give crystals suitable for X-ray diffraction. The Cl- salt 
was purified by chromatography and was then suitable for 
crystallization with the DNA sequence d(TCGGCGCCGA)2. 
In some previous work we have found that well diffracting 
crystals could only be obtained with some DNA sequences by 
starting with the pure enantiomeric complex and the desired 
DNA oligonucleotide. In this case, the crystallisation was 
completely enantioselective and, on crystallization of the 
chloride salt of the racemic complex of the cation with the DNA 
decamer sequence d(TCGCCGCCGA)2, red crystals were 
obtained.  Diffraction data to 1.5 Å resolution were collected on 
beamline I02 at Diamond Light Source Ltd. Data collection and 
refinement statistics are given in Table S1. 
Figure 2 – Asymmetric angled binding by the lambda enantiomers of substituted 
[Ru(TAP)2(dppz)]
2+ complexes viewed from the C2-G9 base pair side.[17] Of particular 
note is the similarity in binding between all complexes besides the 11-CN-dppz 
derivative.  
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  What was quite unexpected, and previously unobserved, was 
the efficiency of the nitrile substituent in anchoring the terminal 
adenine base (A10), with the creation of a complete intercalation 
cavity at the terminal T1C2/G9A10 step of the duplex (Figure 3 
a,b,d). The complete assembly (Figure 3a) has twofold 
symmetry about the central steps. The orientation of the dppz 
ligand is determined by the contact between TAP1 and the 2-
deoxyribose sugar of cytosine (Figure 3b). The bound dppz 
moiety is still not aligned with the Ru-N square plane (Figure 
S3b). The level of detail visible at 1.5 Å resolution (Figure S2) is 
sufficient to show partial disorder of the 11-CN substituent in the 
resulting structure. Electron density fitting revealed the presence 
of a minor component, giving the best fit at 0.33 occupancy. As 
with previously reported structures using this sequence, the 
crystals contained only the lambda enantiomer of the complex, 
at a binding stoichiometry of 1:1 complex to single DNA strand. 
Further details of backbone conformation and water structure 
are shown in Figures S3 and S4. 
The structure shows a ~50 kink at the central G5C6/G5C6 step, 
previously seen in our reversible crystal dehydration study for 
the less hydrated form.[33] In that work, the dehydration produced 
a remarkable switch from an open purine cavity, in the hydrated 
crystal, to an open pyrimidine cavity in the dehydrated crystal. In 
the present example, both sides of the cavity are complete,    
and the crystal form was obtained without the use of a humidity 
controlled environment. The asymmetry of the cavity is shown 
by the  backbone dihedral angles, which are 189 on the 
‘pyrimidine side’ and 63 on the ‘purine side’ (see Discussion 
section and Table 1 for comparisons). Table S2 lists the derived 
parameters for all the structures discussed here, and Figures S5 
and S6 show the extent of the stacking between the dppz ligand 
and the G9 base. The N7 of the guanine base is close to the  
11-CN position. A barium cation originating from the 
crystallization solution is present in the major groove at the 
G3G4/C7C8 step, where TAP2 semi-intercalates, forming a 50 
kink as we have previously observed, and which accounts for 
the complete enantioselectivity of the crystal packing. The Ba-Ba 
distance is 8.0 Å, suggesting an intermediate degree of 
hydration, also supported by the short c axial direction (a = 
47.88 Å, c = 29.14 Å) consistent with that previously reported.[33] 
The orientation of the dppz chromophore is determined by the 
cytosine C2 sugar ring face contacts to the deoxyribose 
hydrogen atoms of C1, C2 and C4 with the TAP2 ligand, as 
described in our previous paper concerning the effect of the 
orientation of inosine substitution at this position.[27] The major 
orientation of the nitrile substituent is on the G9-A10 (the ‘purine 
side’) of the complete intercalation cavity. 
Figure 3 – The lambda enantiomers of (I) and (II) crystallised with the DNA sequence d(TCGGCGCCGA)2. Any hydrogen atoms are shown in calculated positions. (a) The complete 
duplex assembly containing two asymmetric units (one coloured, one off white), omitting the symmetry generated complexes that interact at the G3G4/C7C8  step. The standard 
nucleic acid colour scheme of the Nucleic Acid Database is used for the bases, and Ba2+ ions have been coloured silver; (b) 2Fo-Fc electron density map for (I) showing the major 
orientation of the dppz ligand. The cyan map is countoured at 0.29 e/Å3 and the red map at 0.44 e/Å3 ;  (c) 2Fo-Fc electron density map for (II) showing the major and minor Br 
orientations, with map contoured at 0.29 e/Å3 ;  (d) The ordered complete intercalation cavity with (I), contour levels as in (b); (e) The complete duplex assembly of (II) bound to 
d(TCGGCGCCGA)2 containing two asymmetric units and a symmetry related strand (shown in orange) that forms a reverese Hoogsteen base pair to complete the intercalation cavity.  
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Crystal structure of (II) with d(TCGGCGCCGA)2. [Ru(TAP)2(11-
Br-dppz)]2+ (II) was then synthesised using a variation of a 
previously published method as both the PF6- and Cl- salts, with 
the latter used for crystallisation with DNA. The crystal structure 
of -(II) with the sequence d(TCGGCGCCGA)2 was determined 
to better than 1.1 Å resolution (Table S1), giving an extremely 
clear map (Figure 3c). The structure obtained (Figure 3e) was 
isomorphous to that seen with the -11-Cl analogue with a 
flipped-out A10 stacked on a symmetry equivalent dppz ligand 
and 2:1 disorder of the 11-Br-dppz  ligand.[30] The major Br 
orientation is on the ‘purine side’ of the open intercalation cavity. 
Unlike the effect of 11-CN substitution, there is no water network 
around the Br positions, despite the high data resolution and the 
location of 88 water molecules per DNA strand (Figures S7 and 
S8). The Br atom projects directly into the disordered part of the 
solvent space. The Ba-Ba distance in the major groove is 9.40 Å, 
as previously observed for the -11-Cl analogue, and is 
associated with the fully hydrated form of this structure. A 
comparison of Figures 3b and 3c highlights the difference in 
adenine (A10) orientation resulting from the different 
intercalation cavities.  
Crystal structure of (III) with d(CCGGACCCGG/CCGGGTCCGG). 
The symmetrical compound [Ru(TAP)2(11,12-diCN-dppz)]2+ (III) 
was then synthesised for comparison. Attempted crystallisation 
of the racemic chloride salt with d(TCGGCGCCGA)2 was 
unsuccessful, but crystals were obtained with  closely related 
decamer sequences. The best diffracting crystals, to 1.67 Å 
resolution (Table S1), were obtained with the asymmetric central 
step A5C6/G5T6 generated by sequence combination 
d(CCGGACCCGG/CCGGGTCCGG) (Figure 1c and Figure 4). 
This crystal structure also showed complete cavity formation, 
and because of the central asymmetry, was solved and refined 
in the lower symmetry space group P43, in which the asymmetric 
unit is the full duplex, as shown in Figure 4a and Figures S9 and 
S10. The CN substituents protrude into the solvent cavity from 
the major groove of the DNA, as shown in Figures 4b and 4c, 
and do not overlap directly with the DNA bases. Figure 4d 
shows that the orientation of the dppz is determined by the 
TAP1-cytosine C2 contact, so that the nitrile groups are not 
contained within the DNA base stack. At the intercalation cavity 
there is evidence of backbone disorder, and the phosphate 
group of residue G10 was modelled as a mixture of BI and BII 
conformations.[34] As we have previously seen with the 
unsubstituted dppz and this sequence,[25] there is a reversal in 
the conformation of the terminal guanine base G10, so that it 
stacks in a syn conformation with the negative, and normally 
major groove face of the guanine stacked over the pyrazine ring, 
and aligning the 2-NH2 vector direction of the guanine with one 
Figure 4 – The lambda enantiomer of (III) crystallised with the DNA sequences d(CCGGACCCGG) and d(CCGGGTCCGG), where both strands combine stoichiometrically. (a) 
shows the complete duplex assembly (one asymmetric unit) omitting the symmetry generated complexes that interact at the G3G4/C7C8 step. The structure was solved/refined in 
space group P43 where 50:50 disorder at the central step is observed (not shown). Standard nucleic acid colour scheme is used and Ba
2+ ions have been coloured silver with red 
oxygen atoms (depicting water). Projections of the (b) C2-G9 and (c) C1-G10 base pair, onto the dppz ligand plane, omitting other residues. (d) Space filling representation of the 
C2-deoxyribose sugar contact with the ligand TAP1, which determines the angle of intercalation of the dppz ligand in the cavity.  
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of the ligand -CN groups. Further details of map quality and 
water structure are shown in Figures S9 and S10. 
 
Discussion 
This first study of the comparative effect of nitrile and bromo 
substitution on dppz binding has highlighted both the effect of 
electron withdrawal and of an additional lone pair donor on the 
distal ring of the dppz. The structural evidence is that it affects 
both the base stacking and the solvent water interactions. 
 
Cavity stabilisation/base stacking. The structural work 
reported here shows the unexpected effect of a substituent 
nitrile on the dppz ligand in stabilising the intercalation cavity 
formed by a TA basepair (Figure 5).  It causes the T1-C2 side of 
the intercalation cavity to adopt the expanded backbone 
conformation with  dihedral angle of 189 (Table 1 and Figure 
S3). Our previous work on the structure of rac-[Ru(phen)2dppz]2+ 
with the hexamer duplex d(ATGCAT)2 also showed asymmetric 
complete cavities, for both enantiomers of the complex, and in 
that work could be directly related back to the luminescence 
behaviour of the enantiomers.[26] The crucial effect of backbone 
expansion on luminescence behaviour is the increased 
exposure of the dppz ligand to luminescence quenching, due to 
the additional hydrogen bonding by solvent water. X-ray 
crystallography has been uniquely useful in interpretation of 
such differences. 
 
Table 1 – Selected γ dihedral angles ()   for crystal structures of 
d(TCGGCGCCGA)2 with a range of derivatised dppz complexes. 
Complex PDB Accession Nº γ(T1/C2) γ(G9/A10) 
Λ-[Ru(TAP)2(10-Me-dppz)]2+ 4MJ9 58.4 187.2 
Λ-[Ru(TAP)2(11-Me-dppz)]2+ 4X18 59.7 189.5 
Λ-[Ru(TAP)2(10,12-Me2-dppz)]2+ 4X1A 59.9 190.7 
Λ-[Ru(TAP)2(11,12-Me2-dppz)]2+ 4E8S 59 186.5 
Λ-[Ru(TAP)2(11-Cl-dppz)]2+ 4III 57.7 194 
Λ-[Ru(TAP)2(11-Br-dppz)]2+ 6GLD 55.6 61.2 
Λ-[Ru(TAP)2(11-CN-dppz)]2+ 5NBE 188.9 63.2 
 
 
Table 1 compares the dihedral angles derived in the present 
work for the T1C2/G9A10 step with those from our previous 
work on -Cl and -Me substitution, which in every case gave  
dihedral angles in the gauche range of 57-60 on the pyrimidine 
side.[30,35] In all these cases the cavity was incomplete. 
Interestingly, for the first time with the 11-Br substitution we see 
a gauche dihedral angle at the purine G9-A10 as well, which on 
closer inspection reveals that, what in the other structures is an 
unfavourable interaction, may instead be an attractive interaction 
between the C3-OH and the bromine atom, with an O3-Br 
separation of 4.2 Å.  
The closure of the intercalation cavity with the 11-CN substituent 
suggest both strong electron withdrawal and a favourable 
stacking interaction. Since intercalation is favoured by the π-π 
stacking interactions of the intercalating moiety with the 
surrounding base pairs, altering the π quadrupole of the 
interacting complex should modify the binding affinity. 
Nucleobases, especially guanine, are electron rich, and due to 
the electrostatic repulsions caused by direct overlap of π orbitals, 
sandwich and parallel-displaced stacking formations favour less 
negative π density. Therefore  the electron withdrawing nitrile 
group on the ligand presumably polarises the dppz, relocating π 
electron density away from the interacting π orbitals, 
rationalising the favourable π-π stacking interactions seen here. 
This observation suggests a design lead for more specific 
binding agents, by the direct modification of the π framework. 
Perhaps in this manner much weaker bound base steps or base 
mismatch/mutations could be targeted by such fine tuning of 
electronic properties. The targeting of mismatches probably 
requires enantiomer separation, since that is (structurally) a 
property of the delta enantiomer. [36,37] Such distal ring 
derivatisation has been shown to increase cellular uptake and 
heighten the potency of the proposed PDT photosensitizers.[13] 
 
Nitrile group orientation and water structure. The major 
orientation of the 11-CN substituent, shown in both Figures 3 
and 5, and for the 11-Br substituent in Figure 3, corresponds to 
that previously seen for 11-Me and 11-Cl substitution.[30,35] The 
effect on the water structure is different, however. Here we 
observe direct hydrogen bonding to the nitrile N atom when 
bound to DNA (Figure S4), also present with the 11,12-diCN 
ligand (Figure S10), creating additional water ordering. Strikingly, 
the methyl group substitution seen with the asymmetric 10-Me-, 
11-Me- and 10,12-Me2-dppz[35] are the most strongly directional 
(where total ordering was seen with X-ray data to 0.9 Å 
resolution in each of these cases), and here  the ordered water 
creates a cage around the ligand, but there is no ordered water 
structure around the methyl groups in the major groove (Figure 
S11). The 11-Br structure studied in this work is a substituent 
with a steric effect very similar to that of methyl group, and also 
does not generate any water ordering (Figure S8b). The methyl 
Figure 5 – Crystal structures of (a) Λ-[Ru(TAP)2(dppz)]
2+ and (b) Λ-[Ru(TAP)2(11-CN-
dppz)]2+ bound to DNA sequence d(TCGGCGCCGA)2 highlighting the differences in 
intercalation cavity. The symmetry related strand is shown as light pink showing how the 
terminal adenine (A10) flips out, whereas the A10 in (b) is anchored, forming a closed 
cavity and gauche  torsion angle. 
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group is also the most hydrophobic and electron donating of 
those studied, but nevertheless did not stabilise the intercalation 
cavity. This difference suggests that we can distinguish 
hydrophobic, steric, and electronic effects on orientation, and 
propose that the alternative orientation for methyl substituents is 
strongly disfavoured by the preference of the more hydrophobic 
substituent to remain within the intercalation cavity rather than 
project into the major groove. Intercalatory interactions are 
energetically favourable, especially so when intercalation 
disturbs the hydration sphere of the binding site such as with the 
methylated complexes. Such logic has been used to explain why 
the binding constant for analogous methylated complexes is 
larger than that of the unsubstituted parent. [38] Therefore we 
hypothesise that the effects on orientation of asymmetrically 
substituted moeties are not only a consequence of a balance 
between the attractive polar contacts/Van der Waals forces and 
the increased entropy of hydration on binding,  but additionally 
the hydrophobicity of the dppz substituent. Further systematic 
studies will be needed to confirm this proposal.     
Stabilisation of syn guanine. A final point of note is the role of 
purines in the stabilising of stacking interactions, particularly the 
different adenine and guanine orientations consistent with their 
differing polarities, and previously seen with the unsubstituted 
dppz ligand.[25] Figure 6 summarises this difference, comparing 
both the two purine bases as well as the introduction of the 
electron withdrawing substituent. The adenine base stacks on 
the 11-CN dppz ring to give a normal AT basepair, with the 6-
amino substituent pointing towards the major groove and the 
depth of intercalation determined by the hydrogen atom at the 2-
position. In contrast, the guanine base stacks directly over the 
11,12-diCNdppz ligand, with the 6-carbonyl group directed away 
from the nitrile substituents and over one pyrazine N atom. The 
amino substituent, in the 2-position, is again directed toward the 
major groove and the nitrile substituents. The guanine is thus 
stabilised in a syn conformation, even though there is no 
stabilisation due to additional hydrogen bond formation. 
A new conclusion which can be drawn is that the guanine 
alignment is unaffected by the introduction of the electron 
withdrawing substituent. Comparing Figures 6b and 6c, the 
guanine orientation is almost identical, with no contact to the 
ancillary TAP or phen ligand, but a precise alignment of the 
carbonyl group over one pyrazine N. The adenine comparison is 
now possible because of the effect of the 11-CN substitution in 
figure 6a. Here the adenine H2 is in contact with the TAP2 
ligand and may therefore influence the depth of intercalation. 
Figures 6d and 6e show the greater stacking of the guanine 
compared to adenine, and the differing amino and carbonyl 
orientations. 
Substituted dppz ligands bound to platinum have shown 
interesting G-quadruplex binding properties, [39] and this area 
merits further study, as syn-guanine stabilisation could be key to 
the conformation adopted. [5] 
 
 
Conclusions 
In our crystallographic studies of ruthenium polypyridyl 
complex/oligonucleotide interactions, we have sought to provide 
a rationale for the design of new, more structurally specific 
compounds, and a means of interpreting biophysical data. The 
present work evolved from this approach, where the new 
compounds were chosen for their probable crystallisability and 
desirable TRIR reporting abilities. They have shown the 
orienting effect of asymmetric dppz substitution but also the 
unexpected additional stability conferred on the intercalation 
cavity by a single nitrile group, a property not shared by halogen 
or methyl substitution. We propose that by altering the electronic 
quadrupole moment of the dppz by substituent effects we create 
a preferable π-stacking arrangement for intercalation, and can 
infer that by controlling the electronic properties further we may 
see a higher specificity for electron rich or deficient base steps. 
Further, based on previous structures we suggest that the 
orientation of asymmetrically derivatised intercalators will 
depend on the hydrophobicity of the substituents, an observation 
which will aid the design of better targeted intercalators. A 
systematic understanding of such interactions is indispensable 
in improving our comprehension of the excited state 
photophysics of these systems, where structural knowledge 
helps to elucidate observations in solution phase.  
Further studies with other substituents will allow us to further 
understand the balance between electronic, hydrophobic and 
steric effects. Further comparative studies are also required to 
establish whether the syn guanine stabilisation is enantiospecific. 
To date it has not been observed for the delta enantiomer. 
Experimental Section 
Synthetic Reagents and Materials 
Figure 6 – Adenine and guanine stacking with the dppz ligand, showing the connection 
to base polarity. Adenine adopts the anti (Watson-Crick) conformation, wheras guanine 
adopts the syn (Hoogsteen) conformation. The difference can be related to the polarity 
of the bases. (a) The stacking of A10 on the 11-CN substituted dppz, seen for the first 
time in this work; (b) the stacking of G10 on the 11,12-diCN-dppz chromophore, 
reported here. (c) Comparison with the corresponding dppz-G10 stacking seen 
previously. (d) and (e) show stick representations of (a) and (b) highlighting the 
directionality of the polarity of the bases.  
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Unless otherwise stated, all materials and chemicals were 
sourced from Sigma Aldrich (Merck) or Honeywell research 
chemicals. Sephadex C-25 stationary phase anion exchange 
resin was purchased from GE Healthcare. All solvents, unless 
otherwise stated, were obtained at HPLC grade and used 
without further purification. Where further purification was 
needed, protocol from “Purification of Laboratory Chemicals, 4th 
edition, Armarego et. al.” was followed. Deuterated solvents for 
NMR analysis were purchased either through Sigma-Aldrich or 
Cambridge Isotope Laboratories. 
 
Synthesis of Ruthenium Complexes (I) - (III).  
Syntheses of the novel nitrile derivatives of [Ru(TAP)2(dppz)]2+ 
were carried out by modifying existing literature methods.[22] 
Both were prepared via the condensation of the relevant 
aromatic diamine with Ru(TAP)2Cl2, all of which were also 
synthesised by modifying our previously published literature 
methods.[30,35] Ru(TAP)2Cl2 (81 mg, 0.15 mmol) and 11-CN-dppz 
(49 mg, 0.16 mmol) (or 11,12-diCN-dppz (53 mg, 0.16 
mmol)/11-Br-dppz (58 mg, 0.16 mmol)) were suspended 
together in an aqueous ethanol solution (7 mL, 1:1) within a 
CEM microwave tube (10 mL). The violet coloured solution was 
degassed/evacuated with Ar for 15 minutes before being fully 
sealed and installed into a microwave synthesiser. The sample 
was irradiated at 140 W at 60 oC for 40 minutes, yielding a deep 
red/brown solution which was allowed to cool and then filtered in 
vacuo. Subsequent precipitation of the target compound from 
the filtrate was achieved by metathesis via dropwise addition of 
a saturated solution of aqueous potassium hexafluorophosphate 
(KPF6). Isolation of the PF6- salt by suction filtration yielded a 
dark orange/brown solid, which, after washing with cold water (2 
x 2 mL) was allowed to dry in air. Conversion to the chloride 
form was achieved by the dissolution of the crude material in a 
minimal amount of acetonitrile (~5 mL), addition of HPLC grade 
water (10 mL), followed by dry, washed, Amberlite ion exchange 
resin (IRA-400, Cl- form, 2.4 g), covering, and lightly stirring for 
20 hours. Following removal of the resin by gravity filtration, the 
complex was isolated via rotary evaporation and purified on an 
aqueous Sephadex C-25 column using 0.2 M NaCl as the 
mobile phase (eluting as a deep red/orange band).  The 
compound was isolated as the chloride form, after anionic 
exchange via treatment with Amberlite resin (IRA-400, Cl- form, 
2.4 g), to yield the complex as a deep red/brown microcrystalline 
solid. NMR spectra are shown in Figure S1.  
(I) [Ru(TAP)2(11-CN-dppz)]Cl2. (94 mg, 0.11 mmol, 74 %).  δH 
(400 MHz, H2O-d2) – 9.74 (d, J = 8.4 Hz, 2H), 9.02 (dd, J = 3.2, 
6.8 Hz, 2H), 8.99 (d, J = 3.2 Hz, 2H), 8.73 (s, 1H), 8.65 (s, 4H), 
8.53 (dd, J =  7, 12.4 Hz, 2H), 8.47 (d, J = 8.8 Hz, 1H), 8.38 (t, J 
= 2.0 Hz, 2H), 8.24 (d, J = 5.2 Hz, 2H), 8.07 (d, J = 8.8 Hz, 1H) 
and 7.92 ppm (dd, J = 5.2, 8.8 Hz, 2H). δC (101 MHz, H2O-d2) – 
154.8, 154.7, 150.5, 149.1, 148.6, 145.2, 143.5, 142.6, 141.2, 
135.9, 132.8, 132.2, 131.0, 130.6, 127.9 and 114.4 ppm. FT-IR - 
3000 (broad, m, Arom. ν(-C-H)) and 2232 cm-1 (m, Nitrile ν(-
C≡N)). HRMS-ESI (m/z) – Found (M+H+, 386.5536); calc. 
386.5538 (RuC39N13H212+) (σ < 3 ppm). 
(II) [Ru(TAP)2(11,Br-dppz)]Cl2. (86 mg, 0.10 mmol, 66 %).  δH 
(400 MHz, H2O-d2) – 9.71 (d, J = 8.3 Hz, 2H), 9.05-8.96 (m, 4H), 
8.66 (s, 4H), 8.57 (s, 1H), 8.52 (d, J = 2.9 Hz, 1H), 8.47 (d, J = 
2.9 Hz, 1H), 8.37 (t, J = 2.9 Hz, 2H), 8.32 (d, J = 9.1 Hz, 1H), 
8.23-8.17 (m, 2H), 8.13 (dd, J = 9.1, 2.1 Hz, 1H) and 7.88 ppm 
(ddd, J = 8.2, 5.4, 2.7, 2H). HRMS-ESI (m/z) – Found (M+, 
413.0119); calc. 413.0128 (Ru101C38N12BrH212+) (σ < 3 ppm).  
(II) [Ru(TAP)2(11,12-diCN-dppz)]Cl2. (86 mg, 0.10 mmol, 66 %).  
δH (400 MHz, H2O-d2) – 9.80 (d, J = 8.3 Hz, 2H), 9.07-8.90 (m, 
6H), 8.68 (s, 4H), 8.54 (d, J = 3.0 Hz, 2H), 8.40 (d, J = 3.0 Hz, 
2H), 8.28 (d, J = 5.4 Hz, 2H) and 7.95 ppm (dd, J = 8.4, 5.4 Hz, 
2H). δc (101 MHz, H2O-d2) – 150.06, 150.63, 149.24, 149.08, 
148.86, 148.54, 145.32, 145.25, 142.71, 142.28, 141.98, 141.85, 
137.71, 135.22, 132.60, 132.51, 129.83, 127.72, 115.18 and 
114.90 ppm. FT-IR – 3051 (broad, m, Arom. ν(-C-H)) and 2231 
cm-1 (m, Nitrile ν(-C≡N)). HRMS-ESI (m/z) – Found (M+, 
398.5519); calc. 398.5520 (Ru101C40N14H202+) (σ < 3 ppm).  
 
Macromolecular Crystallography 
The oligonucleotides d(TCGGCGCCGA), d(CCGGACCCGG) 
and d(CCGGGTCCGG) were purchased as HPLC purified solids 
from Eurogentec Ltd and used without further purification.  
Crystallisation, data collection and analysis of Λ-(1) with 
d(TCGGCGCCGA)2. Crystals containing the oligonucleotide 
d(TCGGCGCCGA)2 and ligand Λ-[Ru(TAP)2(11-CN-dppz)]Cl2 
were grown via the vapour diffusion method from sitting drops at 
291 K. Crystallisation was observed in a number of conditions 
from the Nucleic Acid Mini-Screen from Hampton Research, 
where the best diffracting example came from a 8µL drop 
containing; 125 µM d(TCGGCGCCGA)2, 750 µM rac-
[Ru(TAP)2(11-CN-dppz)]Cl2, 7.5% v/v MPD, 30 mM pH 7 sodium 
cacodylate, 9 mM spermine tetrahydrochloride, 60 mM KCl and 
15 mM BaCl2, all equilibrated against 500 µL of 35% v/v MPD. 
Orange/red rods grew following roughly 3 weeks of incubation at 
291 K.  
Diffraction data were collected from single, nitrogen flash-cooled 
crystal fragments at 100 K on beamline I02 at Diamond Light 
Source, Ltd. Data were automatically processed with xia2[40], 
using XDS[41] and XSCALE to integrate and merge peaks from 
all collected images; yielding 5452 unique reflections. The 
structure was solved using single-wavelength anomalous 
dispersion (SAD), using the anomalous diffraction of barium, 
with the SHELXC/D/E package[42]. The model was built by hand, 
using Wincoot[43], and refined against the original data using 
Refmac 5.0[44] in the CCP4 suite[45]. Ligand restraints were 
calculated using eLBOW[46] from the phenix [47] package. As a 
result of the asymmetry of the intercalating ligand, two sites of 
non-integer occupancy are observed. This was fitted by refining 
the occupancy of two complete complexes in the two mirrored 
orientations, with the sum adding to 100% occupancy This 
procedure preserves the correct restraints, and also is 
appropriate to the actual situation in the crystal used.  5% of 
reflections were reserved for the Rfree set. The final model has 
an Rcryst/Rfree of 0.16/0.19 and has been deposited in the Protein 
Data Bank with ID 5NBE. 
Crystallisation, data collection and analysis of Λ-(II) with 
d(TCGGCGCCGA)2. Crystals containing the oligonucleotide 
d(TCGGCGCCGA)2 and ligand Λ-[Ru(TAP)2(11-Br-dppz)]Cl2 
were grown via the vapour diffusion method from sitting drops at 
291 K. Crystallisation was observed in a number of conditions 
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from the Nucleic Acid Mini-Screen from Hampton Research, 
where the best diffracting example came from a 8µL drop 
containing; 125 µM d(TCGGCGCCGA)2, 625 µM rac-
[Ru(TAP)2(11-Br-dppz)]Cl2, 7.5% v/v MPD, 30 mM pH 7 sodium 
cacodylate, 9 mM spermine tetrahydrochloride, 60 mM KCl and 
15 mM BaCl2, all equilibrated against 500 µL of 35% v/v MPD. 
Orange/red rods grew following roughly 3 weeks of incubation at 
291 K.  
Diffraction data were collected from single, nitrogen flash-cooled 
crystal fragments at 100 K on beamline I03 at Diamond Light 
Source, Ltd. Data were automatically processed with xia2[40], 
using DIALS[48] and Aimless[49] to integrate and merge peaks 
from all collected images; yielding 16,081 unique reflections. 
The structure was solved using single-wavelength anomalous 
dispersion (SAD), using the anomalous diffraction of barium, 
with the SHELXC/D/E package[42]. The model was built by hand, 
using Wincoot[43], and refined against the original data using 
Phaser[50] in the Phenix software package[51]. Ligand restraints 
were calculated using eLBOW [46] from the phenix[47] package. 
As a result of the asymmetry of the intercalating ligand, two sites 
of non-integer occupancy are observed. This was fitted by 
refining the occupancy of two complete complexes in the two 
mirrored orientations, with the sum adding to 100% occupancy 
This procedure preserves the correct restraints, and also is 
appropriate to the actual situation in the crystal used. 5% of 
reflections were reserved for the Rfree set. The final model has 
an Rcryst/Rfree of 0.15/0.16 and has been deposited in the Protein 
Data Bank with ID 6GLD. 
Crystallisation, data collection and analysis of Λ-(III) with 
asymmetric decamer d(CCGGACCCGG)/d(CCGGGTCCGG). 
Crystals were grown from sitting drops by vapour diffusion at 
291 K. The drop contained the premixed and annealed duplex 
DNA at a concentration of 125 µM 
d(CCGGACCCGG)/d(CCGGGTCCGG), 125 µM rac-
[Ru(TAP)2(11,12-diCN-dppz)]Cl2, 7.5% v/v MPD, 30 mM pH 7 
sodium cacodylate, 9 mM spermine tetrahydrochloride, 60 mM 
KCl and 15 mM BaCl2, equilibrated against 500 µL of 35% v/v 
MPD. Orange crystals grew after several weeks. A large 
crystalline fragment was obtained from a larger sample using a 
microloop with an elongated aperture to give crystal dimensions 
of 60 µm x 30 µm x 100 µm).  
Diffraction data were collected from a single, nitrogen flash-
cooled crystal at 100 K on beamline I03 at Diamond Light 
Source, Ltd. Data were processed with xia2, using DIALS[48] and 
Aimless[49] to integrate and merge peaks from all collected 
images. The structure was solved using MR-SAD, using the 
anomalous diffraction of barium, with Phaser[50] in the Phenix 
software package[51]. Ligand restraints were calculated using 
eLBOW [46]  from the phenix [47] package. 5% of reflections were 
reserved for the Rfree set. The final model has an Rcryst/Rfree of 
0.19/0.20 and has been deposited in the Protein Data Bank with 
ID 6G8S. Analysis of DNA dihedral angles was performed using 
DNATCO[34]. Structural diagrams were created using PyMol 
(Schrödinger).  
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